Astec Lifesciences (NSE:ASTEC) Long-Term Debt: ₹500 Mil (As of Mar. 2026)


NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
75 GF Score
Price ₹689.20
GF Value ₹990.64
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Long-Term Debt?

Astec Lifesciences NSE:ASTEC +0.37% 75 Long-Term Debt is ₹500 Mil as of Mar. 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 75/100 and a GF Value™ of ₹990.64 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Astec Lifesciences's Long-Term Debt for the quarter that ended in Mar. 2026 was ₹500 Mil.

Astec Lifesciences's quarterly Long-Term Debt declined from Sep. 2025 (₹1,190 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹500 Mil).

Astec Lifesciences's annual Long-Term Debt increased from Mar. 2024 (₹1,990 Mil) to Mar. 2025 (₹2,800 Mil) but then declined from Mar. 2025 (₹2,800 Mil) to Mar. 2026 (₹500 Mil).

Astec Lifesciences  (NSE:ASTEC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Astec Lifesciences Long-Term Debt Related Terms

Astec Lifesciences Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Long-Term Debt Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 108.63 1,990.00 2,800.00 500.00

Astec Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,800.00 0.00 1,190.00 0.00 500.00
NSE:ASTEC
75GF Score
Astec Lifesciences Ltd NSE:ASTEC
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹500 Mil mean?
Astec Lifesciences (NSE:ASTEC) has a Long-Term Debt of ₹500 Mil as of Mar. 2026.
Is Astec Lifesciences' Long-Term Debt too high?
Astec Lifesciences' current Long-Term Debt is ₹500 Mil. Overall, Astec Lifesciences has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Long-Term Debt compare to CTVA and CF?
Astec Lifesciences' Long-Term Debt of ₹500 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for an Agriculture company?
A good Long-Term Debt depends on the Agriculture industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Astec Lifesciences's current Long-Term Debt is ₹500 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹990.64, compared to a current price of ₹689.20 — trading 30.4% below its estimated fair value. The current Long-Term Debt is ₹500 Mil. Astec Lifesciences' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Long-Term Debt is ₹500 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹689.20 is trading 30.4% below its estimated GF Value™ of ₹990.64. GuruFocus considers Astec Lifesciences to be Significantly Undervalued.

Key valuation signals for NSE:ASTEC:

  • Long-Term Debt: ₹500 Mil
  • GF Value™: ₹990.64 vs. price of ₹689.20 (30.4% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
75GF Score

Get the complete analysis for NSE:ASTEC

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹689.20
Price
₹990.64
GF Value